GZR102
GZR102-T2D-201
Phase 2 small_molecule active
Quick answer
GZR102 for Type 2 Diabetes Mellitus (T2DM) is a Phase 2 program (small_molecule) at Gan & Lee Pharmaceuticals. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gan & Lee Pharmaceuticals.
- Indication
- Type 2 Diabetes Mellitus (T2DM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active